Trump Crushes Biotech, Gives Investors A Gift Buying Opportunity

57 0
Soon to be President Donald Trump gave investors a gift. The smart ones could not refuse. The Donald trashed biotech in his press conference causing a massive sell-off. Select biotech stocks that took a beaten, hit major support levels and offered investors an extremely cheap valuation buying level. In my opinion, this is the case with Endo International plc (NASDAQ:ENDP). The stock flushed into a major double bottom support level at $13.75. Based on valuation metrics, this is down right cheap. In addition, this tough talk on biotech drug pricing is nothing new. It has been going on for well over a year. In my opinion, there is little downside left as everything has been factored in. I believe this was a gift buying opportunity on many biotechnology stocks like Endo International plc (NASDAQ:ENDP). Others that are interesting are Gildead Sciences, Valeant Pharma and Teva Pharma .
ZH 简体中文
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 繁體中文
AR العربية
HE עברית
首页 股票筛选器 外汇筛选器 加密货币筛选器 财经日历 如何运作 图表功能 网站规则 版主 网站 & 经纪商解决方案 插件 图表库 功能请求 博客 & 新闻 常见问题 帮助 & 维基 Twitter
概述 个人资料设置 账号和账单 我的客服工单 联系支持 已发表观点 粉丝 正在关注 私人消息 聊天 退出